RSS

Owlstone Medical

Researchers from the Cancer Research Centre in Cambridge have launched a clinical trial to develop a breath test for multiple cancers. Read more

News

Diagnostics company, Owlstone Medical, has raised $15 million to drive the global commercialisation of its Breath Biopsy device. Read more

Devices

Pilot study demonstrates FAIMS technology can detect patients inadequately prepped prior to colonoscopy with 100% sensitivity Read more

News

Diagnostics company Owlstone Medical has welcomed Tony Blair to its headquarters in Cambridge. Read more

News

Diagnostics company Owlstone Medical has commenced a 1,400 patient clinical trial for the early detection of colorectal cancer. Read more

News